Squarepoint’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Squarepoint’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,375	Closed	-$127K	–	4016
2022 Q4	$127K	Buy	+11,375	New	+$110K	﹤0.01%	2917
2022 Q1	–	Sell	-16,953	Closed	-$310K	–	3795
2021 Q4	$310K	Sell	16,953 -3,092	-15%	-$39.2K	﹤0.01%	2430
2021 Q3	$238K	Buy	+20,045	New	+$292K	﹤0.01%	2385
2021 Q1	–	Sell	-17,672	Closed	-$333K	–	3793
2020 Q4	$333K	Buy	+17,672	New	+$381K	﹤0.01%	2131

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Squarepoint's OYST Position: Q1 2023 in Review

Squarepoint sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 11,375 shares — an estimated $127K sold.

Squarepoint first reported a position in OYST in Q4 2020 and held it in 4 quarters. The position peaked at $333K in Q4 2020. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Squarepoint reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Squarepoint sold 11,375 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $127K.
Squarepoint first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
Squarepoint's Oyster Point Pharma, Inc. Common Stock position peaked at $333K in Q4 2020.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.